JAVI-DSR is a combination of Rabeprazole Sodium 20 mg (Enteric Coated) and Domperidone 30 mg (Sustained Release) formulated for the effective management of acid-related gastrointestinal disorders. It combines the acid-suppressing action of Rabeprazole with the prokinetic effect of Domperidone to provide rapid and sustained relief from acidity, heartburn, acid reflux, nausea, bloating, and indigestion.
Key Benefits
- Fast and effective relief from heartburn and acidity
- Reduces excess stomach acid production
- Improves symptoms of GERD (Gastroesophageal Reflux Disease)
- Relieves acid regurgitation and belching
- Helps reduce nausea and vomiting
- Improves gastric emptying and digestive motility
- Provides relief from bloating, fullness, and post-meal discomfort
- Sustained-release formulation for prolonged symptom control.
Composition
Each Hard Gelatin Capsule Contains:
- Rabeprazole Sodium (Enteric Coated) IP – 20 mg
- Domperidone (Sustained Release) IP – 30 mg
Therapeutic Indications
JAVI-DSR may be prescribed for the management of:
- Gastroesophageal Reflux Disease (GERD)
- Acid Reflux
- Heartburn
- Dyspepsia (Indigestion)
- Gastritis
- Hyperacidity
- Nausea & Vomiting associated with gastric disorders
- Bloating and Early Satiety
- Peptic Ulcer Disease (as advised by the physician).
How It Works
Rabeprazole is a Proton Pump Inhibitor (PPI) that suppresses gastric acid secretion by inhibiting the proton pump in the stomach.
Domperidone is a prokinetic agent that enhances gastrointestinal motility, accelerates gastric emptying, and helps reduce nausea, vomiting, bloating, and reflux symptoms.
Together, they provide comprehensive relief from acid-related digestive disorders while improving gastric function.
Packaging
- JAVI-DSR Capsules
- Pack Size: 10 × 10 Capsules
Storage
- Store below 30°C in a cool and dry place.
- Protect from moisture and direct sunlight.
- Keep out of reach of children.
Prescription Information
Schedule Prescription Drug
To be used only under the supervision of a Registered Medical Practitioner. Dosage and duration of treatment should be determined by the treating physician based on the patient's clinical condition.
